Tiger Brokers

  • Quotes
  • Products
    • Cash Boost Account
    • US Stocks
    • US Fractional Shares
    • HK Stocks
    • China A-shares
    • Options
    • Futures
    • US Treasury
    • Auto-invest
    • Fixed Coupon Notes
    • Tiger BOSS Debit Card
    • Fund Mall
    • Tiger Vault
    • Tiger Open Platform
    • Wealth
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Tiger Vault
      • Features of Tiger Vault
      • Transaction Fees
    • Statement
      • Statement
      • Dividends
  • Learn
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
  • Careers
    • L.E.A.P Programme
    • Investment Representative
    • Careers Portal
  • LOGIN
  • SIGN UP
HK StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

ESSEX BIO-TECH

4.260
-0.180-4.05%
Volume:1.35M
Turnover:5.72M
Market Cap:2.42B
PE:7.87
High:4.350
Open:4.290
Low:4.160
Close:4.440
Loading ...
OverviewCompanyNewsFilings

Phase 3 Study for Henlius, Essex's Wet Age-Related Macular Degeneration Drug Reaches Primary Endpoint; Essex Shares Up 11%

MT Newswires Live
·
03 Apr

Stock Track | Essex Bio-Technology Soars 5.26% Following HK$0.06 Per Share Dividend Proposal

Stock Track
·
27 Mar

Stock Track | Essex Bio-Tech Soars 5.26% on Proposed Final Dividend Announcement

Stock Track
·
27 Mar

Essex Bio-Technology - Propose a Final Dividend of HK$0.06 per Ordinary Share

THOMSON REUTERS
·
26 Mar

Essex Bio-Technology FY Net Income HKD 307.2 Million

THOMSON REUTERS
·
26 Mar

Essex Bio-Technology Unit's Co-Developed Drug Completes LPLV for Phase 3 Clinical Study

MT Newswires Live
·
06 Jan

BRIEF-Essex Bio-Technology Says Approval To Commercialise Eye Drops From NMPA

Reuters
·
24 Dec 2024

Analyst Rate

 
 
 
 

Corporate Actions

Ex-dividend Date
May 23, 2025 Dividend Per Share 0.06 HKD
Financial Report Announcement
Mar 26, 2025 Post Market
Ex-dividend Date
Sep 09, 2024 Dividend Per Share 0.06 HKD
Ex-dividend Date
Sep 06, 2024 Dividend Per Share 0.06 HKD
Financial Report Announcement
Aug 26, 2024 Post Market

Dividend History

Ex-DateDividend
2015-05-130.022
2016-05-110.025
2017-05-090.032
2017-09-280.025
2018-05-150.025

Valuation Analysis

8.19
Current
8.31
Sector Average
54.89%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
8.19
Maximum
20.62
+1 STD
11.55
Minimum
4.43
-1 STD
5.07
Average
8.31

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.